Circular RNA therapeutics: navigating the macrophage response in ischemic heart disease
Authors:
- Iokfai CheangICIokfai Cheang
- Sitong ChenSCSitong Chen
- Xinli LiXinli Li
Open Access
- 16 July 2026
- journal article
- Published by OAE Publishing Inc. in The Journal of Cardiovascular Aging
- Vol. 6 (3)
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Macrophage-specific circular RNA circHIPK2, inflammation, and fibrosis after myocardial infarctionEuropean Heart Journal, 2026
- Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023JACC, 2025
- The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implicationsSignal Transduction and Targeted Therapy, 2025
- Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PETNuclear Medicine and Biology, 2024
- Harnessing human genetics and stem cells for precision cardiovascular medicineCell Genomics, 2023
- Clinical delivery of circular RNA: Lessons learned from RNA drug developmentAdvanced Drug Delivery Reviews, 2023
- Autophagy-mediated circHIPK2 promotes lipopolysaccharide-induced astrocytic inflammation via SIGMAR1International Immunopharmacology, 2023
- Epicardial adipose tissue in contemporary cardiologyNature Reviews Cardiology, 2022
- Inflammation, Aging, and Cardiovascular DiseaseJACC, 2022
- The inflammatory response in myocardial injury, repair, and remodellingNature Reviews Cardiology, 2014